CRP and inflammatory bowel disease: These findings suggest that systemic inflammation, which is mediated via the IL-6–CRP signaling pathway, may influence the gut–brain axis, contributing to the neuropsychological burden in IBD, with intestinal inflammation associated with comorbid anxiety and depressive symptoms.